Fen-Yu Tseng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fen-Yu Tseng has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
- Wei-Shiung Yang
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
11 shared publications - Tien-Chun Chang
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
8 shared publications Chuan-Jen Hsu
Departments of Otolaryngology
7 shared publicationsYuh-Shyang Chen
Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipe
6 shared publications- Chih-Yuan Wang
School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
5 shared publications Yen-Ting Chen
Graduate Institute of Clinical Medicine, College of Medicine
5 shared publications
Latest Publications
- Open Access
- 11 May 2023
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 123, S104-S113
The role of confirmatory tests in the diagnosis of primary aldosteronism
- 11 May 2023
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 123, S104-S113
Open AccessThe role of confirmatory tests in the diagnosis of primary aldosteronism
- Open Access
- 10 May 2023
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 123, S98-S103
Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
- 10 May 2023
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 123, S98-S103
Open AccessAldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
- Open Access
- 19 November 2022
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 42 (3) , 357-375
2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation
Radiofrequency ablation (RFA) is a minimally invasive management strategy that has been widely applied for benign and recurrent malignant thyroid lesions as an alternative to surgery in Taiwan. Members of academic societies for specialists in interventional radiology, endocrinology, and endocrine surgery collaborated to develop the first consensus regarding thyroid RFA in Taiwan. The modified Delphi method was used to reach a consensus. Based on a comprehensive review of recent and valuable literature and expert opinions, the recommendations included indications, pre-procedural evaluations, procedural techniques, post-procedural monitoring, efficacy, and safety, providing a comprehensive review of the application of RFA. The consensus effectively consolidates advice regarding thyroid RFA in clinical practice for local experts.
- 19 November 2022
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 42 (3) , 357-375
Open Access2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation
Radiofrequency ablation (RFA) is a minimally invasive management strategy that has been widely applied for benign and recurrent malignant thyroid lesions as an alternative to surgery in Taiwan. Members of academic societies for specialists in interventional radiology, endocrinology, and endocrine surgery collaborated to develop the first consensus regarding thyroid RFA in Taiwan. The modified Delphi method was used to reach a consensus. Based on a comprehensive review of recent and valuable literature and expert opinions, the recommendations included indications, pre-procedural evaluations, procedural techniques, post-procedural monitoring, efficacy, and safety, providing a comprehensive review of the application of RFA. The consensus effectively consolidates advice regarding thyroid RFA in clinical practice for local experts.
- Open Access
- 15 July 2020
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (1) , 588-593
Status of endocrinology and metabolism specialists in Taiwan
- 15 July 2020
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (1) , 588-593
Open AccessStatus of endocrinology and metabolism specialists in Taiwan
- Open Access
- 1 January 2020
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 119 (1) , 538-543
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
- 1 January 2020
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 119 (1) , 538-543
Open AccessImmediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
- 27 December 2019
- Published by Wiley in Anatomical Sciences Education
- Vol. 13 (6) , 743-758
A Web‐Based Virtual Microscopy Platform for Improving Academic Performance in Histology and Pathology Laboratory Courses: A Pilot Study
Virtual microscopy (VM) has been utilized to improve students' learning experience in microscope laboratory sessions, but minimal attention has been given to determining how to use VM more effectively. The study examined the influence of VM on academic performance and teacher and student perceptions and compared laboratory test scores before and after VM incorporation. A total of 662 third‐year students studying histology and 651 fourth‐year students studying pathology were divided into two groups. The light microscopy (LM) group used a light microscope in 2014 and 2015, while the LM + VM group used the VM platform and a light microscope in 2016 and 2017. Four factors positively predict laboratory scores (R square, 0.323; P < 0.001): (i) the pathology course and test‐enhanced learning, (ii) the VM platform and experience, (iii) medical students and lecture scores, and (iv) female students. The LM + VM group exhibited less score variability on laboratory examinations relative to their mean than the LM group. The LM + VM group was also associated with fewer failing grades (F grade; odds ratio, 0.336; P < 0.001) and higher scores (A grade; odds ratio, 2.084; P < 0.001) after controlling for sex, school, course, and lecture grades. The positive effect of the VM platform on laboratory test grades was associated with prior experience using the VM platform and was synergistic with more interim tests. Both teachers and students agreed that the VM platform enhanced laboratory learning. The incorporation of the VM platform in the context of test‐enhanced learning may help more students to master microscopic laboratory content.
- 27 December 2019
- Published by Wiley in Anatomical Sciences Education
- Vol. 13 (6) , 743-758
A Web‐Based Virtual Microscopy Platform for Improving Academic Performance in Histology and Pathology Laboratory Courses: A Pilot Study
Virtual microscopy (VM) has been utilized to improve students' learning experience in microscope laboratory sessions, but minimal attention has been given to determining how to use VM more effectively. The study examined the influence of VM on academic performance and teacher and student perceptions and compared laboratory test scores before and after VM incorporation. A total of 662 third‐year students studying histology and 651 fourth‐year students studying pathology were divided into two groups. The light microscopy (LM) group used a light microscope in 2014 and 2015, while the LM + VM group used the VM platform and a light microscope in 2016 and 2017. Four factors positively predict laboratory scores (R square, 0.323; P < 0.001): (i) the pathology course and test‐enhanced learning, (ii) the VM platform and experience, (iii) medical students and lecture scores, and (iv) female students. The LM + VM group exhibited less score variability on laboratory examinations relative to their mean than the LM group. The LM + VM group was also associated with fewer failing grades (F grade; odds ratio, 0.336; P < 0.001) and higher scores (A grade; odds ratio, 2.084; P < 0.001) after controlling for sex, school, course, and lecture grades. The positive effect of the VM platform on laboratory test grades was associated with prior experience using the VM platform and was synergistic with more interim tests. Both teachers and students agreed that the VM platform enhanced laboratory learning. The incorporation of the VM platform in the context of test‐enhanced learning may help more students to master microscopic laboratory content.
- Open Access
- 1 November 2019
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (11) , 1488-1493
Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry
- 1 November 2019
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (11) , 1488-1493
Open AccessCorrelations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry
- Open Access
- 1 October 2019
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (10) , 1416-1422
Advanced physical examination training course improves medical students' confidence in physical examination
- 1 October 2019
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (10) , 1416-1422
Open AccessAdvanced physical examination training course improves medical students' confidence in physical examination
- Open Access
- 1 March 2019
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (11) , e14862
Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves’ disease patients with hyperthyroidism or subjects with euthyroidism
Insulin-like growth factor 1 (IGF-1) has a molecular structure similar to that of insulin. As an essential mediator of growth hormone, IGF-1 plays a vital role in growth of children and anabolic effects of adults. We evaluated the serum levels of IGF-1 in patients with hyperthyroidism or euthyroidism. In this study, 30 patients each of Graves’ disease with hyperthyroidism (HY group) and euthyroid individuals (EU group) were recruited. The HY patients were treated with antithyroid regimens as clinically indicated. No medications were given to EU patients. The demographic characteristics and anthropometric and laboratory data of both groups at baseline and 6 months were compared. Associations between levels of IGF-1 and free thyroxine (fT4), thyroid-stimulating hormone (TSH), or log transformation of TSH (logTSH) were analyzed. At baseline, the HY patients had significantly higher serum IGF-1 levels than EU patients (median [Q1, Q3]: 305.4 [257.4, 368.1] vs. 236.7 [184.6, 318.8] ng/mL, P = .007). At 6 months, the HY patients still had higher serum levels of IGF-1 than EU patients (299.5 [249.9, 397.9] vs 222.1 [190.2, 305.4] ng/mL, P = .003). At baseline, the serum levels of IGF-1 in the HY and EU patients were positively associated with fT4 (β = 29.02, P = .002) and negatively associated with TSH (β = −31.46, P = .042) and logTSH (β = −29.04, P = .007). The associations between serum levels of IGF-1 with fT4 or TSH became insignificant at 6 months. However, the serum IGF-1 levels had persistent negative associations with logTSH at 6 months (β = −26.65, P = .021). The negative associations between IGF-1 and logTSH at baseline and 6 months remained significant even after adjustment with sex and age (β = −20.22, P = .023 and β = −20.51, P = .024, respectively). The HY patients had higher serum IGF-1 levels than EU patients. The serum IGF-1 concentrations were negatively associated with logTSH in patients with hyperthyroidism or euthyroidism.
- 1 March 2019
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (11) , e14862
Open AccessSerum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves’ disease patients with hyperthyroidism or subjects with euthyroidism
Insulin-like growth factor 1 (IGF-1) has a molecular structure similar to that of insulin. As an essential mediator of growth hormone, IGF-1 plays a vital role in growth of children and anabolic effects of adults. We evaluated the serum levels of IGF-1 in patients with hyperthyroidism or euthyroidism. In this study, 30 patients each of Graves’ disease with hyperthyroidism (HY group) and euthyroid individuals (EU group) were recruited. The HY patients were treated with antithyroid regimens as clinically indicated. No medications were given to EU patients. The demographic characteristics and anthropometric and laboratory data of both groups at baseline and 6 months were compared. Associations between levels of IGF-1 and free thyroxine (fT4), thyroid-stimulating hormone (TSH), or log transformation of TSH (logTSH) were analyzed. At baseline, the HY patients had significantly higher serum IGF-1 levels than EU patients (median [Q1, Q3]: 305.4 [257.4, 368.1] vs. 236.7 [184.6, 318.8] ng/mL, P = .007). At 6 months, the HY patients still had higher serum levels of IGF-1 than EU patients (299.5 [249.9, 397.9] vs 222.1 [190.2, 305.4] ng/mL, P = .003). At baseline, the serum levels of IGF-1 in the HY and EU patients were positively associated with fT4 (β = 29.02, P = .002) and negatively associated with TSH (β = −31.46, P = .042) and logTSH (β = −29.04, P = .007). The associations between serum levels of IGF-1 with fT4 or TSH became insignificant at 6 months. However, the serum IGF-1 levels had persistent negative associations with logTSH at 6 months (β = −26.65, P = .021). The negative associations between IGF-1 and logTSH at baseline and 6 months remained significant even after adjustment with sex and age (β = −20.22, P = .023 and β = −20.51, P = .024, respectively). The HY patients had higher serum IGF-1 levels than EU patients. The serum IGF-1 concentrations were negatively associated with logTSH in patients with hyperthyroidism or euthyroidism.
- Open Access
- 14 February 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (2) , e0212341
The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome
Spot 14 (S14) protein is primarily expressed in adipogenic tissues. Compared to wild type, S14 knockout mice had better resistance to diet-induced obesity and glucose tolerance. However, the association between serum S14 level and metabolic variables in humans has never been investigated. The objectives of this study were to evaluate the associations between serum S14 concentrations with components of metabolic syndrome (MetS). A total of 327 subjects were recruited in this cross-sectional study and categorized by presence of MetS. The mean serum levels of S14 were significantly lower in subjects with MetS than those without (87.1±26.3 μg/L vs. 107.3±40.2 μg/L, ppp = 0.001), low HDL-C (β = -0.149, p = 0.005), and high triglyceride (TG) (β = -0.198, ppp = 0.002), low HDL-C (OR 0.76, 95% CI, 0.61–0.95, p = 0.015) or high TG (OR 0.65, 95% CI, 0.51–0.83, p = 0.001) was reduced with a dose response trend. Our analysis revealed that patients with MetS had lower serum S14 levels than those without. Negative associations existed between MetS, central obesity, high TG, low HDL-C and logS14.
- 14 February 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (2) , e0212341
Open AccessThe serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome
Spot 14 (S14) protein is primarily expressed in adipogenic tissues. Compared to wild type, S14 knockout mice had better resistance to diet-induced obesity and glucose tolerance. However, the association between serum S14 level and metabolic variables in humans has never been investigated. The objectives of this study were to evaluate the associations between serum S14 concentrations with components of metabolic syndrome (MetS). A total of 327 subjects were recruited in this cross-sectional study and categorized by presence of MetS. The mean serum levels of S14 were significantly lower in subjects with MetS than those without (87.1±26.3 μg/L vs. 107.3±40.2 μg/L, ppp = 0.001), low HDL-C (β = -0.149, p = 0.005), and high triglyceride (TG) (β = -0.198, ppp = 0.002), low HDL-C (OR 0.76, 95% CI, 0.61–0.95, p = 0.015) or high TG (OR 0.65, 95% CI, 0.51–0.83, p = 0.001) was reduced with a dose response trend. Our analysis revealed that patients with MetS had lower serum S14 levels than those without. Negative associations existed between MetS, central obesity, high TG, low HDL-C and logS14.